| Open source drug discovery with the malaria box compound collection for neglected diseases and beyond WC Van Voorhis, JH Adams, R Adelfio, V Ahyong, MH Akabas, P Alano, ... PLoS pathogens 12 (7), e1005763, 2016 | 318 | 2016 |
| Growing problem of multidrug-resistant enteric pathogens in Africa IN Okeke, OA Aboderin, DK Byarugaba, KK Ojo, JA Opintan Emerging infectious diseases 13 (11), 1640, 2007 | 318 | 2007 |
| Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors KK Ojo, ET Larson, KR Keyloun, LJ Castaneda, AE DeRocher, ... Nature structural & molecular biology 17 (5), 602-607, 2010 | 197 | 2010 |
| Self-medication with antibiotics for the treatment of menstrual symptoms in southwest Nigeria: a cross-sectional study AR Sapkota, ME Coker, RE Rosenberg Goldstein, NL Atkinson, SJ Sweet, ... BMC public health 10, 1-10, 2010 | 170 | 2010 |
| Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii RC Murphy, KK Ojo, ET Larson, A Castellanos-Gonzalez, BGK Perera, ... ACS medicinal chemistry letters 1 (7), 331-335, 2010 | 154* | 2010 |
| Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis B Baragaña, B Forte, R Choi, S Nakazawa Hewitt, JA Bueren-Calabuig, ... Proceedings of the National Academy of Sciences 116 (14), 7015-7020, 2019 | 127 | 2019 |
| Development of Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitors with Potent Anti-Toxoplasma Activity SM Johnson, RC Murphy, JA Geiger, AE DeRocher, Z Zhang, KK Ojo, ... Journal of medicinal chemistry 55 (5), 2416-2426, 2012 | 122 | 2012 |
| Nucleotide sequence and organization of the multiresistance plasmid pSCFS1 from Staphylococcus sciuri C Kehrenberg, KK Ojo, S Schwarz Journal of Antimicrobial Chemotherapy 54 (5), 936-939, 2004 | 122 | 2004 |
| CTX-M-15 extended-spectrum β-lactamase from Nigerian Klebsiella pneumoniae OO Soge, AM Queenan, KK Ojo, BA Adeniyi, MC Roberts Journal of Antimicrobial Chemotherapy 57 (1), 24-30, 2006 | 117 | 2006 |
| Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors KK Ojo, C Pfander, NR Mueller, C Burstroem, ET Larson, CM Bryan, ... The Journal of clinical investigation 122 (6), 2301-2305, 2012 | 116 | 2012 |
| Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy KK Ojo, JR Gillespie, AJ Riechers, AJ Napuli, CLMJ Verlinde, FS Buckner, ... Antimicrobial agents and chemotherapy 52 (10), 3710-3717, 2008 | 115 | 2008 |
| A Specific Inhibitor of PfCDPK4 Blocks Malaria Transmission: Chemical-genetic Validation KK Ojo, RT Eastman, RSR Vidadala, Z Zhang, KL Rivas, R Choi, JD Lutz, ... The Journal of infectious diseases 209 (2), 275-284, 2014 | 104 | 2014 |
| Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with … RSR Vidadala, KL Rivas, KK Ojo, MA Hulverson, JA Zambriski, I Bruzual, ... Journal of medicinal chemistry 59 (13), 6531-6546, 2016 | 95 | 2016 |
| A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis A Castellanos-Gonzalez, AC White Jr, KK Ojo, RSR Vidadala, Z Zhang, ... The Journal of infectious diseases 208 (8), 1342-1348, 2013 | 87 | 2013 |
| Antibiotic resistance genes in multidrug‐resistant Enterococcus spp. and Streptococcus spp. recovered from the indoor air of a large‐scale swine‐feeding operation AR Sapkota, KK Ojo, MC Roberts, KJ Schwab Letters in applied microbiology 43 (5), 534-540, 2006 | 84 | 2006 |
| Invasion of hepatocytes by Plasmodium sporozoites requires cGMP‐dependent protein kinase and calcium dependent protein kinase 4 K Govindasamy, S Jebiwott, DK Jaijyan, A Davidow, KK Ojo, ... Molecular microbiology 102 (2), 349-363, 2016 | 80 | 2016 |
| Novel bumped kinase inhibitors are safe and effective therapeutics in the calf clinical model for cryptosporidiosis DA Schaefer, DP Betzer, KD Smith, ZG Millman, HC Michalski, ... The Journal of infectious diseases 214 (12), 1856-1864, 2016 | 77 | 2016 |
| In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum P Winzer, J Müller, A Aguado-Martínez, M Rahman, V Balmer, V Manser, ... Antimicrobial agents and chemotherapy 59 (10), 6361-6374, 2015 | 77 | 2015 |
| Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1 ET Larson, KK Ojo, RC Murphy, SM Johnson, Z Zhang, JE Kim, DJ Leibly, ... Journal of medicinal chemistry 55 (6), 2803-2810, 2012 | 76 | 2012 |
| The mef(A) Gene Predominates among Seven Macrolide Resistance Genes Identified in Gram-Negative Strains Representing 13 Genera, Isolated from Healthy … KK Ojo, C Ulep, N Van Kirk, H Luis, M Bernardo, J Leitao, MC Roberts Antimicrobial agents and chemotherapy 48 (9), 3451-3456, 2004 | 75 | 2004 |
